Cleared Traditional

K182543 - Wearable Device

Also marketed or referenced as:
Cradle Small Strap, Medium Strap, Large Strap Multiple Device Charger Hospital Starter Package

K182543 is the FDA 510(k) clearance for Wearable Device by Snap40, Ltd.. It is a Class 2 Cardiovascular device (product code MSX) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K182543 · Snap40, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
58d
Days
Class 2
Risk

K182543 is an FDA 510(k) clearance for the Wearable Device. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Snap40, Ltd. (Edinburgh, GB). The FDA issued a Cleared decision on November 14, 2018 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Snap40, Ltd. devices

Submission Details

510(k) Number K182543 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2018
Decision Date November 14, 2018
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 69
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K182543.
Wearable Device, Home Package in Carry Case with Homehub, Home Package in Carry Case without Homehub
K190073 · Current Health , Ltd. · Mar 2019
BeneVision Central Monitoring System
K183238 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Mar 2019
Digistat Smart Central
K180430 · Ascom Ums Srl Unipersonale · Nov 2018
Unite Connect for Clinical Systems
K180566 · Ascom (Sweden) AB · Apr 2018
Athena GTX Device Management Suite (ADMS) Software
K173203 · Athena Gtx · Mar 2018
BeneVision Central Monitoring System
K162607 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Apr 2017